Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

cancer vaccine

  • You have access
    Clinical Trial of a Cancer Vaccine Targeting VEGF and KIF20A in Advanced Biliary Tract Cancer
    MUTSUNORI MURAHASHI, TOSHIHISA TSURUTA, KAZUNARI YAMADA, YASUKI HIJIKATA, HISANOBU OGATA, JUNJI KISHIMOTO, SACHIKO YOSHIMURA, TETSURO HIKICHI, YOICHI NAKANISHI and KENZABURO TANI
    Anticancer Research March 2021, 41 (3) 1485-1496; DOI: https://doi.org/10.21873/anticanres.14907
  • You have access
    Immune Therapeutics in the Treatment of Advanced Gastric and Esophageal Cancer
    ROBIN PARK, STEPHEN WILLIAMSON, ANUP KASI and ANWAAR SAEED
    Anticancer Research October 2018, 38 (10) 5569-5580; DOI: https://doi.org/10.21873/anticanres.12891
  • You have access
    Clinical Implications of CD4+CD25+Foxp3+Regulatory T Cell Frequencies After CHP-MAGE-A4 Cancer Vaccination
    MASATAKA WADA, TAKAHIRO TSUCHIKAWA, NORIAKI KYOGOKU, TAKEHIRO ABIKO, KENGO MIYAUCHI, SHINTARO TAKEUCHI, TOSHIHIKO KUWATANI, TOSHIAKI SHICHINOHE, YOSHIHIRO MIYAHARA, SHINICHI KAGEYAMA, HIROAKI IKEDA, HIROSHI SHIKU and SATOSHI HIRANO
    Anticancer Research March 2018, 38 (3) 1435-1444;
  • You have access
    Cellular Vaccines Modified with Hyper IL6 or Hyper IL11 Combined with Docetaxel in an Orthotopic Prostate Cancer Model
    JACEK MACKIEWICZ, URSZULA KAZIMIERCZAK, MAREK KOTLARSKI, EWELINA DONDAJEWSKA, ANNA KOZŁOWSKA, ELIZA KWIATKOWSKA, ANITA NOWICKA-KOTLARSKA, HANNA DAMS-KOZŁOWSKA, PIOTR JAN WYSOCKI and ANDRZEJ MACKIEWICZ
    Anticancer Research June 2015, 35 (6) 3275-3288;
  • You have access
    Tumor Regression by CD4 T-Cells Primed with Dendritic/Tumor Fusion Cell Vaccines
    SHIGEO KOIDO, YUTAKA ENOMOTO, VASSO APOSTOLOPOULOS and JIANLIN GONG
    Anticancer Research August 2014, 34 (8) 3917-3924;
  • You have access
    Clinical Trial of a 7-Peptide Cocktail Vaccine with Oral Chemotherapy for Patients with Metastatic Colorectal Cancer
    KIYOTAKA OKUNO, FUMIAKI SUGIURA, KEISUKE INOUE and YASUSHI SUKEGAWA
    Anticancer Research June 2014, 34 (6) 3045-3052;
  • You have access
    Characterization of Structure and Direct Antigen Presentation by Dendritic/Tumor-fused Cells as Cancer Vaccines
    SHIGEO KOIDO and JIANLIN GONG
    Anticancer Research February 2013, 33 (2) 347-354;
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire